/
/
Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
A subscription to JoVE is required to view this content. Sign in or start your free trial.
6,616 Views
•
08:43 min
•
January 31, 2020
DOI:
Summary
Automatically generated
This protocol uses G6PI mixed peptides to construct rheumatoid arthritis models that are closer to that of human rheumatoid arthritis in CD4+ T cells and cytokines. High purity invariant natural killer T cells (mainly iNKT2) with specific phenotypes and functions were obtained by in vivo induction and in vitro purification for adoptive immunotherapy.
Read Article
Cite this Article
Meng, M., Chen, S., Gao, X., Liu, H., Wang, Y., Zhang, J., Dou, H., Li, W., Chen, D. Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice. J. Vis. Exp. (155), e60048, doi:10.3791/60048 (2020).
Copy